Lexicon Pharmaceuticals Inc (LXRX)
0.7734
-0.01
(-1.45%)
USD |
NASDAQ |
Dec 27, 16:00
0.7745
0.00 (0.00%)
After-Hours: 20:00
Lexicon Pharmaceuticals Research and Development Expense (Annual): 58.89M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Viatris Inc | 805.20M |
| Halozyme Therapeutics Inc | 76.36M |
| Perspective Therapeutics Inc | 21.31M |
| Quanterix Corp | 26.06M |
| Autonomix Medical Inc | 2.225M |